| Literature DB >> 33505486 |
Elba Dos Santos Ferreira1, Pedro Luiz Rosalen2,3, Bruna Benso3, Janaina de Cássia Orlandi Sardi4, Carina Denny3, Simone Alves de Sousa5, Felipe Queiroga Sarmento Guerra6, Edeltrudes de Oliveira Lima6, Irlan Almeida Freires3, Ricardo Dias de Castro7.
Abstract
In this literature review, we present the main scientific findings on the antifungal activity of essential oils (EOs) applicable for a new drug formulation to treat oral candidiasis. Seven literature databases were systematically searched for eligible in vitro and clinical trials. Selected articles were screened for biological activity, botanical species, phytochemical composition, study design, and methodological quality. A total of 26 articles were included in the review, of which 21 were in vitro studies and 5 clinical trials. The most promising EOs were obtained from Allium tubeorosum, Cinnamomum cassia, Cinnamomum zeylanicum, and Coriandrum sativum L. Among the phytochemicals, citral and thymol were the most active. Clinical trials indicated that the EOs from Pelargonium graveolens and Zataria multiflora are potentially effective to treat oral candidiasis. Further nonclinical and clinical studies with these EO are warranted to determine their potential use and safety for the treatment of oral candidiasis.Entities:
Year: 2021 PMID: 33505486 PMCID: PMC7810551 DOI: 10.1155/2021/1059274
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629